Table 2

Standardized mean differences (SMDs, d) reported for continuous baseline characteristics show well-balanced matched populations; effect size d (absolute values of d: small effect d < 0.2, medium effect d between 0.2 and 0.8, large effect d > 0.8). Values are expressed as a median with interquartile range (IQR); n = 32 per group

RFC–ACSIFC–ACSd
PCI characteristics
 Total stented length (mm)26.0 ± 30.623.0 ± 11.50.08
 Largest stent diameter (mm)3.5 ± 0.503.4 ± 1.00.05
Patient characteristics
 Age (years)62.0 ± 16.7561.0 ± 16.50.04
 BMI (kg/m2)25.5 ± 6.125.6 ± 3.90.08
Laboratory data
 Total cholesterol (mg/l)204.0 ± 61.0179.0 ± 50.20.49
 LDL cholesterol (mg/l)129.0 ± 53.0113.0 ± 44.50.56
 HDL cholesterol (mg/l)40.0 ± 14.050.0 ± 20.00.23
 Serum creatinine (mg/l)0.94 ± 0.20.97 ± 0.20.17
 Hemoglobin (g/dl)14.7 ± 1.814.8 ± 1.60.09
 Leukocytes (per nl)10.5 ± 4.311.0 ± 6.00.16
 hsCRP (mg/l)2.1 ± 5.42.0 ± 3.20.19
ACS characteristics
 CK peak (U/I)902.0 ± 720569.0 ± 1.0630.13
RFC–ACSIFC–ACSd
PCI characteristics
 Total stented length (mm)26.0 ± 30.623.0 ± 11.50.08
 Largest stent diameter (mm)3.5 ± 0.503.4 ± 1.00.05
Patient characteristics
 Age (years)62.0 ± 16.7561.0 ± 16.50.04
 BMI (kg/m2)25.5 ± 6.125.6 ± 3.90.08
Laboratory data
 Total cholesterol (mg/l)204.0 ± 61.0179.0 ± 50.20.49
 LDL cholesterol (mg/l)129.0 ± 53.0113.0 ± 44.50.56
 HDL cholesterol (mg/l)40.0 ± 14.050.0 ± 20.00.23
 Serum creatinine (mg/l)0.94 ± 0.20.97 ± 0.20.17
 Hemoglobin (g/dl)14.7 ± 1.814.8 ± 1.60.09
 Leukocytes (per nl)10.5 ± 4.311.0 ± 6.00.16
 hsCRP (mg/l)2.1 ± 5.42.0 ± 3.20.19
ACS characteristics
 CK peak (U/I)902.0 ± 720569.0 ± 1.0630.13
Table 2

Standardized mean differences (SMDs, d) reported for continuous baseline characteristics show well-balanced matched populations; effect size d (absolute values of d: small effect d < 0.2, medium effect d between 0.2 and 0.8, large effect d > 0.8). Values are expressed as a median with interquartile range (IQR); n = 32 per group

RFC–ACSIFC–ACSd
PCI characteristics
 Total stented length (mm)26.0 ± 30.623.0 ± 11.50.08
 Largest stent diameter (mm)3.5 ± 0.503.4 ± 1.00.05
Patient characteristics
 Age (years)62.0 ± 16.7561.0 ± 16.50.04
 BMI (kg/m2)25.5 ± 6.125.6 ± 3.90.08
Laboratory data
 Total cholesterol (mg/l)204.0 ± 61.0179.0 ± 50.20.49
 LDL cholesterol (mg/l)129.0 ± 53.0113.0 ± 44.50.56
 HDL cholesterol (mg/l)40.0 ± 14.050.0 ± 20.00.23
 Serum creatinine (mg/l)0.94 ± 0.20.97 ± 0.20.17
 Hemoglobin (g/dl)14.7 ± 1.814.8 ± 1.60.09
 Leukocytes (per nl)10.5 ± 4.311.0 ± 6.00.16
 hsCRP (mg/l)2.1 ± 5.42.0 ± 3.20.19
ACS characteristics
 CK peak (U/I)902.0 ± 720569.0 ± 1.0630.13
RFC–ACSIFC–ACSd
PCI characteristics
 Total stented length (mm)26.0 ± 30.623.0 ± 11.50.08
 Largest stent diameter (mm)3.5 ± 0.503.4 ± 1.00.05
Patient characteristics
 Age (years)62.0 ± 16.7561.0 ± 16.50.04
 BMI (kg/m2)25.5 ± 6.125.6 ± 3.90.08
Laboratory data
 Total cholesterol (mg/l)204.0 ± 61.0179.0 ± 50.20.49
 LDL cholesterol (mg/l)129.0 ± 53.0113.0 ± 44.50.56
 HDL cholesterol (mg/l)40.0 ± 14.050.0 ± 20.00.23
 Serum creatinine (mg/l)0.94 ± 0.20.97 ± 0.20.17
 Hemoglobin (g/dl)14.7 ± 1.814.8 ± 1.60.09
 Leukocytes (per nl)10.5 ± 4.311.0 ± 6.00.16
 hsCRP (mg/l)2.1 ± 5.42.0 ± 3.20.19
ACS characteristics
 CK peak (U/I)902.0 ± 720569.0 ± 1.0630.13
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close